Apr 9, 2013, 06:00 AM by Michael Croft

Bio-IT World | The Bio-IT World Conference & Expo begins in Boston this afternoon, and the Expo hall has been bustling as the more than 125 exhibiting companies set up their booths. Here are just some of the early news and announcements coming off the Expo floor so far.

Apr 9, 2013, 06:00 AM by Michael Croft

Bio-IT World | Contributed Commentary | Today’s pharmaceutical industry embraces the electronic laboratory notebook (ELN) as a staple within its labs. Deployments have helped reduce paper, generate efficiencies, provide greater visibility to data, drive standardization and increase collaboration. Within major pharmaceutical companies, the ELN has been a tremendous tool for driving productivity and accelerating the discoveries that speed new and improved drugs to market. Our next focus, as ELN vendors, must be to improve the integration of electronic data capture and sharing with our pharmaceutical customers’ external client systems.

Apr 8, 2013, 13:00 PM by Michael Croft

Bio-IT World News Brief | Ingenuity Systems and Affymetrix have announced that they will co-promote Ingenuity iReport with Affymetrix expression microarray products, coupling statistical analysis and biological interpretation workflow with a gene expression platform.

Apr 8, 2013, 09:00 AM by Michael Croft

eWeek | Google is granting access to its Google Compute Engine cloud environment, offering infrastructure-as-a-service. The access is for customers of its Gold Support package.

Apr 8, 2013, 07:00 AM by Michael Croft

Bio-IT World | While there has been considerable focus of late on new bioinformatics approaches and platforms for the downstream interpretation of genome sequences in a clinical context, there is still a lot of work to be done to improve the quality and consistency of next-gen sequencing variant calling and read alignment. Arpeggi, co-founded by CEO Nir Leibovich, hopes to interface with the community to help establish standards and best practices for NGS data analysis. Bio-IT World editor Kevin Davies recently asked Leibovich to outline his company’s core strengths and business proposition.

Apr 4, 2013, 07:00 AM by Michael Croft

Bio-IT World | The first in an annual series, Bio-IT World's 2013 Life Sciences IT Survey captures a host of trends in bio-IT for the coming year. The forecast: increasing budgets, almost certain data increases, and more clouds.

Apr 4, 2013, 07:00 AM by Michael Croft

Bio-IT World Product Briefs | Life Technologies Corporation announced two new offerings this morning that give users access to the large genomics database compiled by Compendia Biosciences, which the company acquired in October 2012.

Apr 3, 2013, 13:00 PM by Michael Croft

Boston Globe | BIND Therapeutics (recently rechristened from BIND Biosciences) has signed a $160 million per drug collaboration with Pfizer to develop targeted medicines with nanotechnology.

Apr 3, 2013, 07:00 AM by Michael Croft

Bio-IT World | The Skeptical Outsider |The controversy surrounding the $400-million Encode project’s dubious public relations claims surrounding the function of ‘junk DNA’ and the Battelle Institute’s defense of the $3-billion Human Genome Project (HGP) as economically beneficial (as cited in the recent State of the Union address) make this a good time to examine President Obama’s attempts to bring more of American science under centralized direction and control.

Apr 2, 2013, 15:00 PM by Michael Croft

Wired | Geneticist Steve Jones captures the most dangerous words in genetics: "the gene for."

Apr 2, 2013, 09:00 AM by Michael Croft

New York Times | Following hints of the announcement after his State of the Union address in January, President Obama will today formally launch the Brain Research Through Advancing Innovative Neurotechnologies, or Brain for short.

Apr 2, 2013, 07:00 AM by Michael Croft

eWeek | The cloud infrastructure market grew for most major players in the last quarter of 2012, but IBM's share of the market hit a two-year high.

Apr 1, 2013, 10:00 AM by Michael Croft

Bio-IT World News Brief | CycleComputing is set to revolutionize supercomputing with their new offering today: ZeroCompute. The new intelligent orchestration software is designed to accelerate access to HPC and BigData systems.

Mar 29, 2013, 11:00 AM by Michael Croft

Bio-IT World | BOSTON—An interview with Kari Stefansson, the co-founder, CEO, heart and soul of deCODE Genetics, is an experience quite unlike any other biotech executive briefing. Stefansson agreed to an interview during a pit stop in Boston late year, en route to Los Angeles for a trip that was part business, part pleasure. He would be paying a visit to Amgen. A few weeks later, Amgen announced that it was acquiring the Icelandic firm for a cool $415 million.

Mar 29, 2013, 09:00 AM by Michael Croft

Wired | Miinome--a new start up boasting George Church as an advisor--is building a platform that will enable retailers to target advertisements to consumers based on their genetic makeup.

Mar 29, 2013, 07:00 AM by Michael Croft

eWeek | A security audit found that one in six data storage "buckets" on Amazon's S3 storage service is incorrectly set to public. Conducted by vulnerability firm Rapid7, the audit scanned over 12,000 buckets

Mar 29, 2013, 07:00 AM by Michael Croft

ReadWrite | Cloud spending is only set to increase in 2013, and according to Gartner, offerings will become more specialized. The company predicts Desktop-as-a-Service (DaaS), Metal-as-a-Service (MaaS) and DisasterRecovery-as-a-Service (DRaaS) to lead the new product market in 2013.

Mar 28, 2013, 13:00 PM by Michael Croft

MendelsPod | Bio-IT World’s own Kevin Davies, editor-in-chief, shares his thoughts on bioinformatics. This last year has seen a flowering of new companies offering genome interpretation and reporting, but what will success for these early entrants look like?

Mar 28, 2013, 12:00 PM by Michael Croft

The Scientist | Michael Houghton, a Canadian microbiologist and immunologist, declined the prestigious Gairdner International Award because he said two colleagues were also deserving of the prize.

Mar 28, 2013, 09:00 AM by Michael Croft

Bio-IT World Video | At the Bio-IT World Expo last year, an all star panel took on the challenges of combating cancer and “characterizing the alien invader”. Our opportunities in cancer therapies are driven by the availability of data, the panel contented, and our challenges lie in integrating the data. On the eve of the 2013 event, we evaluate our progress.